Hospitalist Doctors in Vero Beach, FL Accepting Medicare

9 Hospitalist doctors found. Showing 1 - 9

Dr. Thet Lin Tun, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1300 36th St, Suite 1g, Vero Beach, FL 32960 Phone: 772-562-3960    Fax: 772-562-3969

Catherine Michelle Kowalski, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1000 36th St, Vero Beach, FL 32960 Phone: 772-567-4311

Teddy Garland Combs Iii, PA-C Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3450 11th Ct, Vero Beach, FL 32960 Phone: 772-299-3511

Dr. Federico Mariano Canavosio Ii, MEDICAL DOCTOR Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1300 36th St Ste 1a, Vero Beach, FL 32960 Phone: 772-925-8230    Fax: 772-925-8235

Monisola O Oni, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 981 37th Pl, Vero Beach, FL 32960 Phone: 772-257-5785    Fax: 772-257-5325

Dr. Irene Rahman-garcia, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1000 36th St, Vero Beach, FL 32960 Phone: 772-567-4311

Katherine Ida Clayton, D.O. Hospitalist Medicare: Medicare Enrolled Practice Location: 1000 36th St, Vero Beach, FL 32960 Phone: 772-567-4311    Fax: 772-563-4641

Dr. Mohamed Elsayed Mahmoud Ghonimy, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1000 36th Street Vero Beach Street, Vero Beach, FL 32960 Phone: 216-442-4836    Fax: 216-636-6063

George A Mitchell, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1000 36th St, Vero Beach, FL 32960 Phone: 772-567-4311

News Archive

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Merck today announced that final results from two pivotal Phase III studies of boceprevir, its investigational oral hepatitis C protease inhibitor, will be presented in oral plenary sessions at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), which is taking place from Oct. 29 through Nov. 2 in Boston. Results for boceprevir in response-guided therapy strategies, which evaluated treatment durations shorter than current standard therapy, will be presented during the meeting.

Ovarian cancer therapy may help treat patients with aggressive pancreatic cancer

A targeted therapy that has shown its power in fighting ovarian cancer in women including those with BRCA1 and BRCA2 mutations may also help patients with aggressive pancreatic cancer who harbor these mutations and have few or no other treatment options.

States mull joining health care reform lawsuits or keeping out of it

The Associated Press/New York Times: Indiana has joined the lawsuit brought by 13 states challenging the constitutionality of a mandate on Americans to carry health insurance in the new health reform law. "State Attorney General Greg Zoeller said Monday that Indiana would be added to an amended version of the lawsuit against the law that is expected to be filed soon" (3/29).

Bile duct cancer treatment could be improved by tailored medication

Treatment of patients suffering from bile duct cancer could be improved by tailoring medication to the levels of a key protein in people with the disease, according to new research.

Read more Medical News

› Verified 4 days ago